Clothiapine
Back to searchMolecule Structure
Scientific Name
Clothiapine
Description of the Drug
Clothiapine is an atypical antipsychotic indicated in the treatment of acute psychosis, exacerbations of chronic psychosis, chronic psychosis, paranoid psychosis, and anxiety.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB13256
http://www.drugbank.ca/drugs/DB13256
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 3 (5-HT3) receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2094132 |
| Dopamine D4 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL219 |
| Serotonin 2 (5-HT2) receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2095200 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL122941 |
| Human Metabolome Database | HMDB0250371 |
| DrugBank | DB13256 |
| PubChem: Thomson Pharma | 15348656 |
| PubChem | 16351 |
| LINCS | LSM-19970 |
| Nikkaji | J3.697H |
| BindingDB | 50040237 |
| EPA CompTox Dashboard | DTXSID5022851 |
| DrugCentral | 717 |
| rxnorm | CLOTHIAPINE |
| ChEBI | 31424 |
| ZINC | ZINC000026185346 |
